IDEXX Labs (IDXX) Tops Q4 EPS by 8c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
IDEXX Laboratories Announces Fourth Quarter and Full Year 2018 Results
February 1, 2019 6:27 AM ESTWESTBROOK, Maine, Feb. 1, 2019 /PRNewswire/ --
Achieves revenue growth in Q4 of 9% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic Reports 15% year-over-year increase in Catalyst placements at new or competitive accounts in Q4, supporting full year growth of 21% in IDEXX's premium instrument installed base Delivers full year EPS of $4.26, representing 45% growth on a reported basis and 36% on a comparable constant currency basis Reaffirms 2019 revenue guidance of $2,385 million - $2,425 million, reflecting consistent expectations for reported... More